Yüklüyor......

A retrospective six-patient series of apatinib for the treatment of persistent or recurrent carcinoma of the cervix

OBJECTIVE: Although advances have been made in the clinical and therapeutic management of women with cervical cancer, the best treatment for patients with metastatic or recurrent cervical cancer is still undefined. Apatinib, a novel inhibitor of vascular endothelial growth factor receptor-2 tyrosine...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Onco Targets Ther
Asıl Yazarlar: Chen, Chao, Qin, Shukui, Li, Zixiong, Luo, Xianwen, Zhang, Yu, Zhang, Jue, Liu, Xiufeng
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove 2019
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6643513/
https://ncbi.nlm.nih.gov/pubmed/31410025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S212536
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!